|
1
|
Stewart BW and Wild CP: World Cancer
Report 2014. International Agency for Research on Cancer World
Health Organization; 2014
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scardino PT, Linehan W Marston, Zelefsky
MJ and Vogelzang NJ: Comprehensive Textbook of Genitourinary
Oncology (4th). Lippincott Williams and Wilkins. Philadelphia, PA:
2011.
|
|
4
|
Höckel M and Vaupel P: Tumor hypoxia:
Definitions and current clinical, biologic, and molecular aspects.
J Natl Cancer Inst. 93:266–276. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamasaki M, Nomura T, Sato F and Mimata H:
Chronic hypoxia induces androgen-independent and invasive behavior
in LNCaP human prostate cancer cells. Urol Oncol. 31:1124–1131.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tan MJ, Teo Z, Sng MK, Zhu P and Tan NS:
Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer
Res. 10:677–688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu P, Goh YY, Chin HF, Kersten S and Tan
NS: Angio-poietin-like 4: A decade of research. Biosci Rep.
32:211–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kersten S, Lichtenstein L, Steenbergen E,
Mudde K, Hendriks HF, Hesselink MK, Schrauwen P and Müller M:
Caloric restriction and exercise increase plasma ANGPTL4 levels in
humans via elevated free fatty acids. Arterioscler Thromb Vasc
Biol. 29:969–974. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mandard S, Zandbergen F, van Straten E,
Wahli W, Kuipers F, Müller M and Kersten S: The fasting-induced
adipose factor/angiopoietin-like protein 4 is physically associated
with lipoproteins and governs plasma lipid levels and adiposity. J
Biol Chem. 281:934–944. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu B, Moser A, Shigenaga JK, Grunfeld C
and Feingold KR: The acute phase response stimulates the expression
of angiopoietin like protein 4. Biochem Biophys Res Commun.
391:1737–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kubo H, Kitajima Y, Kai K, Nakamura J,
Miyake S, Yanagihara K, Morito K, Tanaka T, Shida M and Noshiro H:
Regulation and clinical significance of the hypoxia-induced
expression of ANGPTL4 in gastric cancer. Oncol Lett. 11:1026–1034.
2016.PubMed/NCBI
|
|
13
|
Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC,
Pal M, Lam CR, Boukamp P, Pan JY, Tan SH, et al: Angiopoietin-like
4 protein elevates the prosurvival intracellular O2(−):H2O2 ratio
and confers anoikis resistance to tumors. Cancer Cell. 19:401–415.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ifon ET, Pang AL, Johnson W, Cashman K,
Zimmerman S, Muralidhar S, Chan WY, Casey J and Rosenthal LJ: U94
alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis
of prostate cancer cell line PC3. Cancer Cell Int. 5:19–31. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sato R, Yamasaki M, Hirai K, Matsubara T,
Nomura T, Sato F and Mimata H: Angiopoietin-like protein 2 induces
androgen-independent and malignant behavior in human prostate
cancer cells. Oncol Rep. 33:58–66. 2015.PubMed/NCBI
|
|
16
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim SH, Park YY, Kim SW, Lee JS, Wang D
and DuBois RN: ANGPTL4 induction by prostaglandin E2 under hypoxic
conditions promotes colorectal cancer progression. Cancer Res.
71:7010–7020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rohwer N and Cramer T: Hypoxia-mediated
drug resistance: Novel insights on the functional interaction of
HIFs and cell death pathways. Drug Resist Updat. 14:191–201. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karakashev SV and Reginato MJ: Progress
toward overcoming hypoxia-induced resistance to solid tumor
therapy. Cancer Manag Res. 7:253–264. 2015.PubMed/NCBI
|
|
20
|
Zhang H, Wong CC, Wei H, Gilkes DM,
Korangath P, Chaturvedi P, Schito L, Chen J, Krishnamachary B,
Winnard PT Jr, et al: HIF-1-dependent expression of
angiopoietin-like 4 and L1CAM mediates vascular metastasis of
hypoxic breast cancer cells to the lungs. Oncogene. 31:1757–1770.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li H, Ge C, Zhao F, Yan M, Hu C, Jia D,
Tian H, Zhu M, Chen T, Jiang G, et al: Hypoxia-inducible factor 1
alpha-activated angiopoietin-like protein 4 contributes to tumor
metastasis via vascular cell adhesion molecule-1/integrin β1
signaling in human hepatocellular carcinoma. Hepatology.
54:910–919. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hull GW, Rabbani F, Abbas F, Wheeler TM,
Kattan MW and Scardino PT: Cancer control with radical
prostatectomy alone in 1,000 consecutive patients. J Urol.
167:528–534. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Roehl KA, Han M, Ramos CG, Antenor JA and
Catalona WJ: Cancer progression and survival rates following
anatomical radical retropubic prostatectomy in 3,478 consecutive
patients: Long-term results. J Urol. 172:910–914. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ng KT, Xu A, Cheng Q, Guo DY, Lim ZX, Sun
CK, Fung JH, Poon RT, Fan ST, Lo CM, et al: Clinical relevance and
therapeutic potential of angiopoietin-like protein 4 in
hepatocellular carcinoma. Mol Cancer. 13:196–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakayama T, Hirakawa H, Shibata K, Nazneen
A, Abe K, Nagayasu T and Taguchi T: Expression of angiopoietin-like
4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous
invasion and distant metastasis. Oncol Rep. 25:929–935. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shibata K, Nakayama T, Hirakawa H, Hidaka
S and Nagayasu T: Clinicopathological significance of
angiopoietin-like protein 4 expression in oesophageal squamous cell
carcinoma. J Clin Pathol. 63:1054–1058. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Padua D, Zhang XH, Wang Q, Nadal C, Gerald
WL, Gomis RR and Massagué J: TGFbeta primes breast tumors for lung
metastasis seeding through angiopoietin-like 4. Cell. 133:66–77.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim I, Kim HG, Kim H, Kim HH, Park SK, Uhm
CS, Lee ZH and Koh GY: Hepatic expression, synthesis and secretion
of a novel fibrinogen/angiopoietin-related protein that prevents
endothelial-cell apoptosis. Biochem J. 346:603–610. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang YH, Wang Y, Lam KS, Yau MH, Cheng KK,
Zhang J, Zhu W, Wu D and Xu A: Suppression of the Raf/MEK/ERK
signaling cascade and inhibition of angiogenesis by the carboxyl
terminus of angiopoietin-like protein 4. Arterioscler Thromb Vasc
Biol. 28:835–840. 2008. View Article : Google Scholar : PubMed/NCBI
|
